Role of ellagic acid for the prevention and treatment of liver diseases V Aishwarya, S Solaipriya, V Sivaramakrishnan Phytotherapy Research 35 (6), 2925-2944, 2021 | 53 | 2021 |
Overview of morin and its complementary role as an adjuvant for anticancer agents S Solairaja, MQ Andrabi, NR Dunna, S Venkatabalasubramanian Nutrition and Cancer 73 (6), 927-942, 2021 | 39 | 2021 |
Progesterone receptor membrane component 1 and its accomplice: emerging therapeutic targets in lung cancer S Solairaja, S Ramalingam, NR Dunna, S Venkatabalasubramanian Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug …, 2022 | 9 | 2022 |
Ameliorative role of ellagic acid against acute liver steatosis in adult zebrafish experimental model A Venkatasubramanian, A Thiyagaraj, V Subbiah, S Solairaja, ... Comparative Biochemistry and Physiology Part C: Toxicology & Pharmacology …, 2021 | 7 | 2021 |
Clinical presentation and 2-year mortality outcomes in acute heart failure in a tertiary care hospital in South India: A retrospective cohort study V Munusamy, L Goenka, M Sharma, T Ramamoorthy, D Jha, S Solaipriya, ... Journal of Clinical and Preventive Cardiology 8 (2), 56-63, 2019 | 7 | 2019 |
Computational Identification and Validation of Non-Synonymous SNPs in Progesterone Receptor Membrane Complex 1 Linked to Lung Cancer S Solairaja, SV Habeeb Shaik Mohideen International Journal of Experimental Research and Review 36, 2023 | 3 | 2023 |
Comparison of random and site directed mutation effects on the efficacy between lead SARS-CoV2 anti-protease drugs Indinavir and Hydroxychloroquine JS Sunny, LM Saleena, S Balachandran | 1 | 2020 |
Preclinical Targeting of the PGRMC1-CK2 Axis with Silmitasertib: A Potential Strategy for Lung Adenocarcinoma Therapy S Solaipriya, M Anbalagan, V Sivaramakrishnan Drug Research 74 (04), 187-190, 2024 | | 2024 |
Beyond Hormones: Investigating the Impact of Progesterone Receptor Membrane Component 1 in Lung Adenocarcinoma S Solairaja, S Venkatabalasubramanian The Journal of Membrane Biology, 1-13, 2024 | | 2024 |
Toxicity, Safety, and Pharmacotherapeutic Properties of Ursolic Acid: Current Status, Challenges, and Future Perspectives against Lung Cancer C Subramanian, S Solairaja, NR Dunna, S Venkatabalasubramanian Current Bioactive Compounds 19 (5), 47-62, 2023 | | 2023 |
In Vivo, Ex Vivo, and In Vitro Model Systems for Liver Cancer Research S Solaipriya, N Mahalakshmi, R Prajitha, V Sivaramakrishnan Handbook of Animal Models and its Uses in Cancer Research, 353-373, 2023 | | 2023 |